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Nephrotic syndrome (NS) refers to the tetrad of edema, “nephrotic range” (>1 g/m2 bovine serum albumin) proteinuria, recurrent edema, hypoalbuminemia, and 
hyperlipidemia. NS remains the most common manifestation of 
glomerular diseases in childhood. Despite the initial response rate 
of 90–95% and the favorable prognosis in children with steroid-
sensitive NS (SSNS), relapse occurs in 60–90% of the initial 
responders which can lead to increased morbidity, complications, 
and decreased quality of life [1-5].
The course of illness in children with SSNS varies from a 
single episode to infrequent or frequent relapses and, rarely, the 
occurrence of late steroid resistance [6-8]. The management of 
patients with frequent relapse, steroid dependence, and late 
resistance is difficult, often requiring the use of alternative agents. 
Information on the course of NS is available from multiple 
cohorts, including that of the International Study of Kidney 
Diseases in Children [2,11]. Risk factor for frequent relapses 
includes the early age of onset, short initial therapy, delay time 
to remission, and brief duration of the first remission [2,12-16]. 
The understanding of factors that determine the course is useful in 
decision regarding therapy and enables good counseling.
While the management of the initial episode and choice of 
alternative medication have changed over the years, there are 
limited contemporized data on the outcomes. We reviewed the 
case notes of recent patients, to examine the course of illness and 
its determinants.
MATERIALS AND METHODS
This was a prospective, observational, single center study carried 
out on patients attending a tertiary care hospital with NS. All the 
children between the age of 6 months and 14 years presenting 
with NS between April 2016 and March 2018 (including 1-year 
follow-up period) were included in the study. The study protocol 
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was approved by the institutional ethics committee and written 
informed consent from the parents or guardians was obtained 
before enrolling the patients into the study. All patients were 
followed for a minimum of 12 months.
A detailed history was taken and all the recruited patients 
were examined, and parameters such as clinical presentations, 
investigations, treatment, and other relevant parameters were 
recorded in the case record forms. NS was classified according to 
the consensus statements given by Indian Academy of Pediatrics 
nephrology group on SSNS. The course of disease during these 
12 months was categorized as non-relapse, infrequent relapse, and 
frequent relapse. Frequent relapses were defined as the occurrence 
of >2 relapses in 6 months or >3 relapses in 12 months and steroid 
dependence as the presence of 2 consecutive relapses while on 
tapering doses of prednisone [17-18]. Failure to show remission 
of proteinuria despite 4 weeks’ treatment with prednisolone 
(2 mg/kg/day) was termed as initial resistance when noted at 
the onset of diseases and late resistance if occurring in a patient 
previously responsive to steroids [17].
Hypertension was defined as blood pressure higher than 
95th percentile for sex, age, and height [19]. Short stature was 
defined as height < 2 SD (Z score) mean of age and sex to consider 
long term side effects of steroids while obesity was considered 
significant when body mass index was more than 3 SD for age 
and sex [20]. Patients had regular examination for visual acuity, 
intraocular pressure, and cataract. Tuberculosis was diagnosed if 
the tuberculin test was positive in the presence of clinical and 
radiological features.
Patients have received daily and alternate day prednisolone 
for 6 weeks each. Patients with frequent relapses or steroid 
dependence received prednisolone (0.3–0.7 mg/kg) on alternate 
days for 9–12 months. Those having relapses or steroid toxicity 
received alternative agents such as levamisole (2 mg/kg/day) 
for 6 months or cyclophosphamide (2 mg/kg/day) for 12 weeks. 
Data analysis was done using Microsoft Excel for Windows 
version 2007.
RESULTS
In the present study, a maximum number of the children (63.7%) 
had onset at the age between 1 and 5 years while the mean age of 
presentation was 3.5 years. Among the included children, 29.4% 
were of 6–10 years and the other 6.8% were >10 years. There 
were 62.8% of boys and 39.2% of girls. In the present study, 
38.2% had sustained remission, (until follow-up for 1 year), 
38.2% infrequent relapses, and 23.5% frequent relapse.
All the patients had spot albuminuria 3+ or more with 24 h urinary 
protein >2 g in 82% of patients. In serum biochemistry, all patients 
had serum albumin <2.5 g/dl and serum cholesterol >200 mg/dl. 
After starting steroids therapy in SSNS, 80.3% of patients responded 
within 14 days of daily dose of prednisolone (2 mg/kg/day) while 
6.7% responded after 3 weeks, and 1.1% of patients responded late 
by 28 days. The present study shows that urinary tract infection was 
the most common infection (46.0%) while encephalopathy 3 (2.9%) 
being the least common as shown in Table 1.
Tables 2 and 3 show the treatment given to the enrolled 
patients and the factors which were responsible for the relapse of 
NS, respectively, in the patients.
In our study, Cushingoid features were the most common side 
effect of steroid in 40 (44.9%) patients, followed by infections 
22 (21.5%), hypertension in 16 (17.9%), growth retardation 
12(11.7%), gastrointestinal (GI) symptoms in 6 (6.6%), and 
hyperglycemia in 4 (4.4%) (Table 4).
DISCUSSION
We reported the course of SSNS seen at a tertiary care center 
in North Gujarat, including clinical features, complications 
Table 1: Infections in patients with NS
Types of infections Percentage of patients
UTI 46.0
Respiratory tract infection 24.5
Peritonitis 16.7
Skin infection 4.9
Tuberculosis 3.9
Encephalopathy 2.9
NS: Nephrotic syndrome, UTI: Urinary tract infection
Table 2: Treatment given in NS
Type of treatment Number of patients (%)
Standard dose of steroid 39 (38.2)
Low-dose long-term steroids 54 (52.9)
Second-line drug-levamisole 6 (5.8)
Second-line drug cyclophosphamide 1 (0.9)
NS: Nephrotic syndrome
Table 3: Factors associated with the relapse of NS
Causes Number of patients (%)
Infections 22 (21.5)
Drug defaulter 12 (11.7)
Hypocalcemia 2 (1.9)
Early age of onset (≤5 years) 65 (63.7)
Longer time required for remission (>3 weeks) 1 (1.2)
No relapse in <6 months after remission 24 (23.5)
Table 4: Complications of steroid therapy
Side effect Number of patients (%)
Cushingoid features 40 (44.9)
Infection 22 (21.5)
Hypertension 16 (17.9)
UTI 15 (14.7)
Acute kidney injury 15 (14.7)
Growth retardation 12 (11.7)
GI symptoms 6 (6.7)
Candida 6 (4.9)
Hyperglycemias 4 (4.4)
Hypocalcemia 3 (2.9)
GI: Gastrointestinal, UTI: Urinary tract infection
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of steroid therapy, and number of relapses and risk factor 
associated with the frequent relapse. In our study, mean age of 
presentation was observed 44.3 months which is comparable 
to the studies done by Sinha et al. [6] (48.7 months), 
Safaei and Maleknejad [21] (4.8 months), Ahmadzadeh 
et al. [22] (4.5 years), and Gulati et al. [23] (52 months). The 
characteristics male preponderance of our patients was similar 
to that reported previously by Sinha et al. [6] (76%), Mishra 
et al. [24] (72%), Shrivastav et al. [25] (77%), Safaei and 
Maleknejad [21] (66%), and Adeleke et al. [26] (57%) in their 
studies.
The major presenting symptoms in children were swelling 
(100%), decreased urine output (83.3%), burning micturition 
(52%), fever (44%), edema (47.0%), and hypertension (15.7%). 
The most common sign was facial edema as shown in Figure 1. 
Among all children with NS, 38.2% had no relapse, 38.2 had 
infrequent relapse, 23.5% had frequent relapses, and 14.7% 
were steroid dependent. Children with NS were more prone to 
infection than the general population which is in accordance with 
the previous studies in India [27]. We have observed the high 
prevalence of UTI (46.0%) which is comparable to the studies 
done by Senguttuvam et al. [28] (46%) and Ibadin et al. [29] 
(44.8%). However, Gulati et al. [23] (13.8%), Mc Vicar [30] 
(21%), and Samuel et al. [2] (8.2%) reported a low prevalence of 
UTI in their study population.
In our study, after starting steroid therapy in SSNS, 80.3% of 
patients responded within 14 days of prednisolone (2 mg/kg/day). 
The other 6.7% responded in 3 weeks, and 1.1% of patients 
responded late by 28 days. In a study by Mishra et al. [24], 
43.3% of patients responded in 2 weeks while 15.3% responded 
between 3rd and 4th weeks of treatment. Patients with SSNS, 93%, 
had remission within 2 weeks of starting steroid. Patients with 
frequent relapse or steroid dependence were treated by either 
low-dose long-term steroid or additional immunosuppressant 
drugs. Most of our patients responded well with low-dose long-
term steroids, that is, 12 patients with frequent relapse (50%) and 
8 patients with steroid dependence responded to low-dose long-
term steroids while the remaining patients required additional 
immunosuppressant drugs.
In our study, the side effects of steroids include Cushingoid 
features (44.9%), infections (21.5%), hypertension (17.9%), 
GI symptoms (6.7%), and hyperglycemia (4.49%). Similarly, 
Sinha et al. [6] observed obesity (21%), hypertension (5.8%), 
growth retardation (4.9%), and cataract (1.6%) cases. Gulati et 
al. [23] observed Cushingoid features in 56.7%, hypertension 
in 28.9%, and GI symptoms in 5% of patients. Similar 
observations were made by Hahn et al. [31], Gipson et al. [32], 
and Davin et al. [5].
There is evidence that adequate initial therapy with 
corticosteroids is useful in reducing the risk of subsequent 
relapses. The present study also suggests that extension of initial 
therapy of 9–12 months was associated with reduced proportion 
of patients with frequent relapse. Findings from the present study 
confirm that an early age at onset of NS is associated with risk of 
frequent relapses [12,33,34]. This will help to parents for vigilant 
follow-up in nephrotic clinic in early years of life.
Our study had certain limitations such as short duration of 
follow-up of 1 year with the long-term outcome not known and 
lack of kidney biopsy to determine histopathology. The present 
study reconfirms the importance of age at onset of NS, the need for 
adequate initial steroid therapy, and duration of initial remission 
in predicting the risk of frequent relapses. The outcomes were 
satisfactory, and on follow–up, most of the patients were in 
sustained remission or had infrequent relapses.
CONCLUSIONS
NS in children is a widespread problem which is responsible for 
significant morbidity. In our study, approximately one-fourth 
patients with nephritic syndrome had frequent relapses and risk 
factors for which include onset age, short initial therapy, and 
shorter first remission.
Figure 1: Signs observed in the patients
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